Monday, February 11, 2013 Friday, February 8, 2013 Thursday, February 7, 2013 Wednesday, February 6, 2013- Why Elan Shares Plungedat Motley Fool (Wed, Feb 6)
- 1 Blockbuster Biotech Dealat Motley Fool (Wed, Feb 6)
- Biogen Idec Pays Elan $3.25 Billion For Tysabri: Do We Leave, Or Stay?at Seeking Alpha (Wed, Feb 6)
- A Win-Win Multiple Sclerosis Deal?at Motley Fool (Wed, Feb 6)
- Micron Announces Convertible Notes and 3 Heavily Traded Shares Demanding Attentionat Wall St. Cheat Sheet (Wed, Feb 6)
- Elan Corporation's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Feb 6)
- Stocks Lower In Choppy Trade; Aruba, Trimble Slideat Investor's Business Daily (Wed, Feb 6)
- Who's Going to Buy This Orphan Drugmaker?at Motley Fool (Wed, Feb 6)
- Biogen Idec Paying $3.25 Billion for Full Rights to Tysabriat Motley Fool (Wed, Feb 6)
- Biogen Idec Shares Rise on Deal for Elan's Share of MS Drugat Minyanville (Wed, Feb 6)
- Biogen Stock Hits New High On Tysabri Buyoutat Investor's Business Daily (Wed, Feb 6)
- Biogen gets full rights to 'blockbuster' drugat bizjournals.com (Wed, Feb 6)
- [video] Faber Report: Biogen Idec Buying Stake in MS Drugat CNBC (Wed, Feb 6)
- Early Movers: TWX, CVS, CMI & Moreat CNBC (Wed, Feb 6)
- In Wise Move, Biogen Spends $3.25 Billion For Rest Of Tysabri. Now What Happens To Elan?at Forbes (Wed, Feb 6)
Add ELN News to My Yahoo!   | |
|
0.29(2.10%) 2:11PM EDT - Nasdaq Real Time Price